Investigating Different Mechanisms of Action in Combination Therapy for Influenza

about

Investigating Different Mechanisms of Action in Combination Therapy for Influenza

Item

http://www.wikidata.org/entity/Q58573517

description

im Januar 2018 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Investigating Different Mechanisms of Action in Combination Therapy for Influenza

@en

Investigating Different Mechanisms of Action in Combination Therapy for Influenza

@nl

type

Item

label

Investigating Different Mechanisms of Action in Combination Therapy for Influenza

@en

Investigating Different Mechanisms of Action in Combination Therapy for Influenza

@nl

prefLabel

Investigating Different Mechanisms of Action in Combination Therapy for Influenza

@en

Investigating Different Mechanisms of Action in Combination Therapy for Influenza

@nl

P1476

Investigating Different Mechanisms of Action in Combination Therapy for Influenza

@en

P2093

Hana M Dobrovolny

http://www.w3.org/2001/XMLSchema#string

Kelli Melville

http://www.w3.org/2001/XMLSchema#string

Thalia Rodriguez

http://www.w3.org/2001/XMLSchema#string

P2860

Triple combination of amantadine, ribavirin, and oseltamivir is highly active and synergistic against drug resistant influenza virus strains in vitro

Neuraminidase inhibitor-rimantadine combinations exert additive and synergistic anti-influenza virus effects in MDCK cells

Antiviral therapies on the horizon for influenza

Modeling Influenza Virus Infection: A Roadmap for Influenza Research

Mechanisms of viral mutation

Inhibition of influenza virus replication in mice by GG167 (4-guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid) is consistent with extracellular activity of viral neuraminidase (sialidase)

A review of mathematical models of influenza A infections within a host or cell culture: lessons learned and challenges ahead

Neuraminidase inhibitor resistance in influenza: assessing the danger of its generation and spread

Efficacy of oseltamivir-zanamivir combination compared to each monotherapy for seasonal influenza: a randomized placebo-controlled trial

Triple combination antiviral drug (TCAD) composed of amantadine, oseltamivir, and ribavirin impedes the selection of drug-resistant influenza A virus

P304

1207

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FPHAR.2018.01207

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30405419

http://www.w3.org/2001/XMLSchema#string

P921

Farmakologi

P932

6206389

http://www.w3.org/2001/XMLSchema#string